Literature DB >> 22776384

Measles, rubella, and varicella among the crew of a cruise ship sailing from Florida, United States, 2006.

Kiren Mitruka1, Christina B Felsen, Danitza Tomianovic, Barry Inman, Karen Street, Phyllis Yambor, Susan E Reef.   

Abstract

BACKGROUND: Cruise ship outbreaks of vaccine-preventable diseases (VPD) such as rubella and varicella have been previously associated with introduction and spread among susceptible crew members originating from countries with endemic transmission of these diseases.
METHODS: During February to April 2006, we investigated a cluster of rash illnesses due to measles, rubella, or varicella on a cruise ship sailing from Florida to the Caribbean. Case-finding measures included review of medical logs, active surveillance for rash illness among crew members, and passive surveillance for rash illness in the ship's infirmary lasting two incubation periods from the last case of measles. Passengers with potential exposure to these VPD were notified by letters. All susceptible crew members with potential exposure were administered the measles, mumps, and rubella vaccine after informed consent.
RESULTS: A total of 16 cases were identified only among crew members: 1 rubella, 3 measles (two-generation spread), 11 varicella (three-generation spread), and 1 unknown diagnosis. Of 1,197 crew members evaluated, 4 had proof of immunity to measles and rubella. Based on passive surveillance, no cases were identified among passengers, the majority of whom resided in the United States.
CONCLUSION: The international makeup of the population aboard cruise ships combined with their semi-enclosed environment has the potential to facilitate introduction and spread of VPD such as measles, rubella, and varicella onboard and into communities. Cruise lines should ensure crew members have evidence of immunity to these diseases. Passengers should be up to date with all vaccinations, including those that are travel-specific, prior to embarking on cruise travel. Published 2012. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2012        PMID: 22776384     DOI: 10.1111/j.1708-8305.2012.00620.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  6 in total

1.  Maritime varicella illness and death reporting, U.S., 2010-2015.

Authors:  Marion E Rice; Millicent Bannerman; Mona Marin; Adriana S Lopez; Melissa M Lewis; Caroline E Stamatakis; Joanna J Regan
Journal:  Travel Med Infect Dis       Date:  2018-04-03       Impact factor: 6.211

2.  Maritime illness and death reporting and public health response, United States, 2010-2014.

Authors:  Caroline E Stamatakis; Marion E Rice; Faith M Washburn; Kristopher J Krohn; Millicent Bannerman; Joanna J Regan
Journal:  Travel Med Infect Dis       Date:  2017-10-14       Impact factor: 6.211

3.  Contact infection of infectious disease onboard a cruise ship.

Authors:  Nan Zhang; Ruosong Miao; Hong Huang; Emily Y Y Chan
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

4.  A Systematic Review for Vaccine-Preventable Diseases on Ships: Evidence for Cross-Border Transmission and for Pre-Employment Immunization Need.

Authors:  Varvara A Mouchtouri; Hannah C Lewis; Christos Hadjichristodoulou
Journal:  Int J Environ Res Public Health       Date:  2019-07-30       Impact factor: 3.390

5.  Air Passenger Travel and International Surveillance Data Predict Spatiotemporal Variation in Measles Importations to the United States.

Authors:  Marya L Poterek; Moritz U G Kraemer; Alexander Watts; Kamran Khan; T Alex Perkins
Journal:  Pathogens       Date:  2021-02-03

Review 6.  Systematic Review on Outbreaks of SARS-CoV-2 on Cruise, Navy and Cargo Ships.

Authors:  Ann-Christin Kordsmeyer; Natascha Mojtahedzadeh; Jan Heidrich; Kristina Militzer; Thomas von Münster; Lukas Belz; Hans-Joachim Jensen; Sinan Bakir; Esther Henning; Julian Heuser; Angelina Klein; Nadine Sproessel; Axel Ekkernkamp; Lena Ehlers; Jens de Boer; Scarlett Kleine-Kampmann; Martin Dirksen-Fischer; Anita Plenge-Bönig; Volker Harth; Marcus Oldenburg
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.